The final green light backs NHS use of the drug

The move bolsters the French drug giant’s core R&D areas of autoimmune and allergic diseases

Updated Date: Fri, 07 Aug 2020 00:00:00 EDT

Updated Date: Fri, 07 Aug 2020 00:00:00 EDT

Updated Date: Fri, 07 Aug 2020 00:00:00 EDT

Updated Date: Fri, 07 Aug 2020 00:00:00 EDT

Updated Date: Fri, 07 Aug 2020 00:00:00 EDT

FiercePharmaAsia—Japan COVID-19 vax deals; Samsung Biologics’ $2B super plant; Eisai’s new U.S. HQ aliu Fri, 08/14/2020 – 08:55

Mesoblast scores FDA committee’s backing for cell therapy despite some early worries kblankenship Fri, 08/14/2020 – 09:08

UK books COVID-19 vaccine doses from J&J and Novavax and backs new clinical trials arlene.weintraub Fri, 08/14/2020 – […]